I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
SPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck Cancer
This is a study to investigate the efficacy and safety of ADP-A2M4 in combination with pembrolizumab in HLA-A*02 eligible and MAGE-A4 positive subjects with recurrent or metastatic Head and Neck cancer.
metastatic head and neck carcinoma
squamous cell carcinoma
squamous cell carcinoma of head and neck
head and neck cancer
pembrolizumab
- 0 views
- 05 Aug, 2020